Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-26-011160

Options or other derivatives

  • Chief Financial Officer acquired 62,131 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pamir Ozan · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-19 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +62,131 62,131 D
Loading xslF345X05/wk-form4_1771969576.xml…